Curbing cancer's sweet tooth: Is there a role for MnSOD in regulation of the Warburg effect?

Mitochondrion

Volumn 13, Issue 3, 2013, Pages 170-188

  Holley, Aaron K ^a   Dhar, Sanjit Kumar ^a   St Clair, Daret K ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cancer; Manganese superoxide dismutase; Mitochondria; Reactive oxygen species; Warburg effect

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SIRTUIN 3; MITOCHONDRIAL PROTEIN; SUPEROXIDE DISMUTASE; TUMOR PROTEIN;

AEROBIC METABOLISM; AGING; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CARDIOVASCULAR SYSTEM; CELL METABOLISM; CITRIC ACID CYCLE; EMBRYO DEVELOPMENT; ENERGY METABOLISM; GLYCOLYSIS; HUMAN; IMMUNE SYSTEM; KIDNEY; LIVER; MALIGNANT NEOPLASTIC DISEASE; METABOLIC REGULATION; MITOCHONDRION; MOLECULAR DYNAMICS; NERVOUS SYSTEM; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY CHAIN; REVIEW; SKELETAL MUSCLE; WARBURG EFFECT; ANIMAL; ENZYMOLOGY; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; GLYCOLYSIS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; OXIDATIVE PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84883751942     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2012.07.104     Document Type: Review

References (351)

1. Abate C., Patel L., Rauscher F.J., Curran T. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 1990, 249:1157-1161.
2. Abello N., Kerstjens H.A.M., Postma D.S., Bischoff R. Protein tyrosine nitration: selectivity, physicochemical and biological consequences, denitration, and proteomics methods for the identification of tyrosine-nitrated proteins. J. Proteome Res. 2009, 8:3222-3238.
3. Achanta G., Sasaki R., Feng L., Carew J.S., Lu W., Pelicano H., Keating M.J., Huang P. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA pol gamma. EMBO J. 2005, 24:3483-3492.
4. Adam-Vizi V., Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol. Sci. 2006, 27:639-645.
5. Ahles T.A., Saykin A.J. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat. Rev. Cancer 2007, 7:192-201.
6. Aida Y., Maeyama S., Takakuwa T., Uchikoshi T., Endo Y., Suzuki K., Taniguchi N. Immunohistochemical expression of manganese superoxide dismutase in hepatocellular carcinoma, using a specific monoclonal antibody. J. Gastroenterol. 1994, 29:443-449.
7. Albracht S.P.J. The prosthetic groups in succinate dehydrogenase number and stoichiometry. Biochim. Biophys. Acta 1980, 612:11-28.
8. Albracht S.P.J., Subramanian J. The number of Fe atoms in the iron-sulfur centers of the respiratory chain. Biochim. Biophys. Acta 1977, 462:36-48.
9. Altenberg B., Greulich K.O. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 2004, 84:1014-1020.
10. Andreyev A.Y., Kushnareva Y.E., Starkov A.A. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc.) 2005, 70:246-264.
11. 2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem. J. 2009, 418:29-37.
12. Bakhanashvili M., Grinberg S., Bonda E., Rahav G. Excision of nucleoside analogs in mitochondria by p53 protein. AIDS 2009, 23:779-788.
13. Bakthavatchalu V., Dey S., Xu Y., Noel T., Jungsuwadee P., Holley A.K., Dhar S.K., Batinic-Haberle I., St.Clair D.K. Manganese superoxide dismutase is a mitochondrial fidelity protein that protects Polγ against UV-induced inactivation. Oncogene 2012, 31:2129-2139.
14. Behrend I., Henderson G., Zwacka R.M. Reactive oxygen species in oncogenic transformation. Biochem. Soc. Trans. 2003, 31:1441-1444.
15. Behrend L., Mohr A., Dick T., Zwacka R.M. Manganese superoxide dismutase induces p53-dependent senescence in colorectal cancer cells. Mol. Cell. Biol. 2005, 25:7758-7769.
16. o site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J. Cell Biol. 2007, 177:1029-1036.
17. Bell E.L., Emerling B.M., Ricoult S.J.H., Guarente L. SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production. Oncogene 2011, 30:2986-2996.
18. Bellot G., Garcia-Medina R., Gounon P., Chiche J., Roux D., Pouyssegur J., Mazure N.M. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol. 2009, 29:2570-2581.
19. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N., Nakano K., Bartrons R., Gottlieb E., Vousden K.H. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126:107-120.
20. Berg J.M., Tymoczko J.L., Stryer L. Biochemistry 2002, W. H. Freeman and Company, New York. 5th ed.
21. Berneburg M., Gattermann N., Stege H., Grewe M., Vogelsang K., Ruzicka T., Krutmann J. Chronically ultraviolet-exposed human skin shows a higher mutation frequency of mitochondrial DNA as compared to unexposed skin and the hematopoietic system. Photochem. Photobiol. 1997, 66:271-275.
22. Biaglow J.E., Miller R.A. The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy. Cancer Biol. Ther. 2005, 4:6-13.
23. Birch-Machin M.A., Swalwell H. How mitochondria record the effects of UV exposure and oxidative stress using human skin as a model tissue. Mutagenesis 2010, 25:101-107.
24. Blagosklonny M.V., An W.G., Romanova L.Y., Trepel J., Fojo T., Neckers L. p53 inhibits hypoxia-inducible factor-stimulated transcription. J. Biol. Chem. 1998, 273:11995-11998.
25. Boffoli D., Scacco S.C., Vergari R., Solarino G., Santacroce G., Papa S. Decline with age of the respiratory chain activity in human skeletal muscle. Biochim. Biophys. Acta 1994, 1226:73-82.
26. Bonuccelli G., Tsirigos A., Whitaker-Menezes D., Pavlides S., Pestell R.G., Chiavarina B., Frank P.G., Flomenberg N., Howell A., Martinez-Outschoorn U.E., Sotgia F., Lisanti M.P. Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010, 9:3506-3514.
27. Boonstra J., Post J.A. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 2004, 337:1-13.
28. Borgstahl G.E.O., Parge H.E., Hickey M.J., Beyer W.F., Hallewell R.A., Tainer J.A. The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles. Cell 1992, 71:107-118.
29. Bourdon A., Minai L., Serre V., Jais J.P., Sarzi E., Aubert S., Chretien D., de Lonlay P., Paquis-Flucklinger V., Arakawa H., Nakamura Y., Munnich A., Rotig A. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat. Genet. 2007, 39:776-780.
30. Brand M.D. The sites and topology of mitochondrial superoxide production. Exp. Gerontol. 2010, 45:466-472.
31. Brandon M., Baldi P., Wallace D.C. Mitochondrial mutations in cancer. Oncogene 2006, 25:4647-4662.
32. Briere J.-j., Favier J., Gimenez-Roqueplo A.-P., Rustin P. Tricarboxylic acid cycle dysfunction as a cause of human diseases and tumor formation. Am. J. Physiol. Cell Physiol. 2006, 291:C1114-C1120.
33. Brookes P.S., Yoon Y., Robotham J.L., Anders M.W., Sheu S.-S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 2004, 287:817-833.
34. Brown M.S., Stemmer S.M., Simon J.H., Stears J.C., Jones R.B., Cagnoni P.J., Sheeder J.L. White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. AJNR Am. J. Neuroradiol. 1998, 19:217-221.
35. Budanov A.V., Sablina A.A., Feinstein E., Koonin E.V., Chumakov P.M. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 2004, 304:596-600.
36. 2 in cells and thereby their biological state. Free Radic. Biol. Med. 2006, 41:1338-1350.
37. Cantu D., Schaack J., Patel M. Oxidative inactivation of mitochondrial aconitase results in iron and H2O2-mediated neurotoxicity in rat primary mesencephalic cultures. PLoS One 2009, 4:e7095.
38. Case A.J., McGill J.L., Tygrett L.T., Shirasawa T., Spitz D.R., Waldschmidt T.J., Legge K.L., Domann F.E. Elevated mitochondrial superoxide disrupts normal T cell development, impairing adaptive immune response to an influenza challenge. Free Radic. Biol. Med. 2011, 50:448-458.
39. Cassina A., Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch. Biochem. Biophys. 1996, 328:309-316.
40. Castro L., Rodriquez M., Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J. Biol. Chem. 1994, 269:29409-29415.
41. Chance B., Castor L.N. Some patterns of the respiratory pigments of ascites tumors in mice. Science 1952, 116:200-202.
42. Chance B., Hess B. Spectroscopic evidence of metabolic control. Science 1959, 129:700-708.
43. 2 sensing. J. Biol. Chem. 2000, 275:25130-25138.
44. Chang T.-S., Cho C.-S., Park S., Yu S., Kang S.W. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulate apoptotic signaling by mitochondria. J. Biol. Chem. 2004, 279:41975-41984.
45. Chelikani P., Fita I., Loewen P.C. Diversity of structures and properties among catalases. Cell. Mol. Life Sci. 2004, 61:192-208.
46. Chen X.J., Butow R.A. The organization and inheritance of the mitochondrial genome. Nat. Rev. Genet. 2005, 6:815-825.
47. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., Lesnefsky E.J. Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem. 2003, 278:36027-36031.
48. Chen D., Yu Z., Zhu Z., Lopez C.D. The p53 pathway promotes efficient mitochondrial DNA base excision repair in colorectal cancer cells. Cancer Res. 2006, 66:3485-3494.
49. Chen Z., Lu W., Garcia-Prieto C., Huang P. The Warburg effect and its cancer therapeutic implications. J. Bioenerg. Biomembr. 2007, 39:267-274.
50. Choi J.H., Kim T.N., Kim S., Baek S.H., Kim J.H., Lee S.R., Kim J.R. Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinoma. Anticancer Res. 2002, 22:3331-3335.
51. Chua Y.L., Dufour E., Dassa E.P., Rustin P., Jacobs H.T., Taylor C.T., Hagen T. Stabilization of hypoxia-inducible factor-1α occurs independently of mitochondrial reactive oxygen species production. J. Biol. Chem. 2010, 285:31277-31284.
52. Chuang T.-C., Liu J.-Y., Lin C.-T., Tang Y.-T., Yeh M.-H., Chang S.-C., Li J.-W., Kao M.-C. Human manganese superoxide dismutase suppresses HER2/neu-mediated breast cancer malignancy. FEBS Lett. 2007, 581:4443-4449.
53. Church S.L., Grant J.W., Ridnour L.A., Oberley L.W., Swanson P.E., Meltzer P.S., Trent J.M. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:3113-3117.
54. Connor K.M., Hempel N., Nelson K.K., Dabiri G., Gamarra A., Balarmino J., van de Water L., Mian B.M., Melendez J.A. Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells. Cancer Res. 2007, 67:10260-10267.
55. Copin J.-C., Gasche Y., Chan P.H. Overexpression of copper/zinc superoxide dismutase does not prevent neonatal lethality in mutant mice that lack manganese superoxide dismutase. Free Radic. Biol. Med. 2000, 28:1571-1576.
56. Cortopassi G., Wang E. Modelling the effects of age-related mtDNA mutation accumulation; Complex I deficiency, superoxide and cell death. Biochim. Biophys. Acta 1995, 1271:171-176.
57. Cullen J.J., Weydert C., Hinkhouse M.M., Ritchie J., Domann F.E., Spitz D., Oberley L.W. The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res. 2003, 63:1297-1303.
58. Dang C.V., Le A., Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin. Cancer Res. 2009, 15:6479-6483.
59. Davis C.A., Hearn A.S., Fletcher B., Bickford J., Garcia J.E., Leveque V., Melendez J.A., Silverman D.N., Zucali J., Agarwal A., Nick H.S. Potent anti-tumor effects of an active site mutant of human manganese-superoxide dismutase. Evolutionary conservation of product inhibition. J. Biol. Chem. 2004, 279:12769-12776.
60. de Souza-Pinto N.C., Harris C.C., Bohr V.A. p53 functions in the incorporation step in DNA base excision repair in mouse liver mitochondria. Oncogene 2004, 23:6559-6568.
61. DeBerardinis R.J., Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 2010, 29:313-324.
62. DeBerardinis R.J., Mancuso A., Daikhin E., Nissim I., Yudkoff M., Wehrli S., Thompson C.B. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. 2007, 104:19345-19350.
63. Dhar S.K., St.Clair D.K. Manganese superoxide dismutase regulation and cancer. Free Radic. Biol. Med. 2012, 52:2209-2222.
64. Dhar S.K., Xu Y., Chen Y., St.Clair D.K. Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. J. Biol. Chem. 2006, 281:21698-21709.
65. Dhar S.K., Xu Y., St.Clair D.K. Nuclear factor κB- and specificity protein 1-dependent p53-mediated bi-directional regulation of the human manganese superoxide dismutase gene. J. Biol. Chem. 2010, 285:9835-9846.
66. Dhar S.K., Tangpong J., Chaiswing L., Oberley T.D., St.Clair D.K. Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages. Cancer Res. 2011, 71:6684-6695.
67. + pumping as a link in aging/disease vicious cycle. Int. J. Biochem. Cell Biol. 2008, 40:1792-1805.
68. Drahota Z., Chowdhury S.K.R., Floryk D., Mracek T., Wilhelm J., Rauchova H., Lenaz G., Houstek J. Glycerophosphate-dependent hydrogen peroxide production by brown adipose tissue mitochondria and its activation by ferricyanide. J. Bioenerg. Biomembr. 2002, 34:105-113.
69. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82:47-95.
70. Duttaroy A., Paul A., Kundu M., Belton A. A Sod2 null mutation confers severely reduced adult life span in Drosophila. Genetics 2003, 165:2295-2299.
71. Ebert B.L., Firth J.D., Ratcliffe P.J. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences. J. Biol. Chem. 1995, 270:29083-29089.
72. Esworthy R.S., Ho Y.-S., Chu F.-F. The Gpx1 gene encodes mitochondrial glutathione peroxidase in the mouse liver. Arch. Biochem. Biophys. 1997, 340:59-63.
73. Falkenberg M., Larsson N.-G., Gustafsson C.M. DNA replication and transcription in mammalian mitochondria. Annu. Rev. Biochem. 2007, 76:679-699.
74. Fijalkowska I., Xu W., Comhair S.A.A., Janocha A.J., Mavrakis L.A., Krishnamachary B., Zhen L., Mao T., Richter A., Erzurum S.C., Tuder R.M. Hypoxia inducible-inducible factor1α regulates the metabolic shift of pulmonary hypertensive endothelial cells. Am. J. Pathol. 2010, 176:1130-1138.
75. Finley L.W.S., Carracedo A., Lee J., Souza A., Egia A., Zhang J., Teruya-Feldstein J., Moreira P.I., Cardoso S.M., Clish C.B., Pandolfi P.P., Haigis M.C. SIRT3 opposes reprograming of cancer cell metabolism through HIF1α destabilization. Cancer Cell 2011, 19:416-428.
76. Firth J.D., Ebert B.L., Ratcliffe P.J. Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J. Biol. Chem. 1995, 270:21021-21027.
77. Flynn J.M., Choi S.W., Day N.U., Gerencser A.A., Hubbard A., Melov S. Impaired spare respiratory capacity in cortical synaptosomes from Sod2 null mice. Free Radic. Biol. Med. 2011, 50:866-873.
78. Fogg V.C., Lanning N.J., MacKeigan J.P. Mitochondria in cancer: at the crossroads of life and death. Chin. J. Cancer 2011, 30:526-539.
79. Fojta M., Kubicarova T., Vojtesek B. Effect of p53 protein redox states on binding to supercoiled and linear DNA. J. Biol. Chem. 1999, 274:25749-25755.
80. Folz R.J., Crapo J.D. Extracellular superoxide dismutase (SOD3): tissue-specific expression, genomic characterization, and computer-assisted sequence analysis of the human EC SOD gene. Genomics 1994, 22:162-171.
81. 3+ and its role in enzyme-generated hydroxyl radical formation. Chem. Biol. Interact. 1976, 15:77-89.
82. Forman H.J., Kennedy J. Superoxide production and electron transport in mitochondrial oxidation of dihydroorotic acid. J. Biol. Chem. 1975, 250:4322-4326.
83. Forman H.J., Kennedy J. Dihydroorotate-dependent superoxide production in rat brain and liver: a function of the primary dehydrogenase. Arch. Biochem. Biophys. 1976, 173:219-224.
84. Forman H.J., Fukuto J.M., Torres M. Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am. J. Physiol. Cell Physiol. 2004, 287:C246-C256.
85. Fridovich I. The biology of oxygen radicals. Science 1978, 201:875-880.
86. Fridovich I. Superoxide dismutases. An adaptation to a paramagnetic gas. J. Biol. Chem. 1989, 264:7761-7764.
87. Fridovich I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 1995, 64:97-112.
88. Fukuda R., Zhang H., Kim J.-w., Shimoda L., Dang C.V., Semenza G.L. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007, 129:111-122.
89. Galanis A., Pappa A., Giannakakis A., Lanitis E., Dangaj D., Sandaltzopoulos R. Reactive oxygen species and HIF-1 signaling in cancer. Cancer Lett. 2008, 266:12-20.
90. Galeotti T., Wohlrab H., Borrello S., De Leo M.E. Messenger RNA for manganese and copper-zinc superoxide dismutases in hepatomas: correlation with degree of differentiation. Biochem. Biophys. Res. Commun. 1989, 165:581-589.
91. Garcia-Ramirez M., Francisco G., Garcia-Arumi E., Hernandez C., Martinez R., Andreu A.L., Simo R. Mitochondrial DNA oxidation and manganese superoxide dismutase activity in peripheral blood mononuclear cells fro type 2 diabetic patients. Diabetes Metab. 2008, 34:117-124.
92. Gardner P.R., Raineri I., Epstein L.B., White C.W. Superoxide radical and iron modulate aconitase activity in mammalian cells. J. Biol. Chem. 1995, 270:13399-13405.
93. Garrido N., Griparic L., Jokitalo E., Wartiovaara J., van der Bliek A.M., Spelbrink J.N. Composition and dynamics of human mitochondrial nucleoids. Mol. Biol. Cell 2003, 14:1583-1596.
94. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 2004, 4:891-899.
95. Genova M.L., Ventura B., Giuliano G., Bovina C., Formiggini G., Castelli G.P., Lenaz G. The site of production of superoxide radical in mitochondrial complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2. FEBS Lett. 2001, 505:364-368.
96. Gius D., Spitz D.R. Redox signaling in cancer biology. Antioxid. Redox Signal. 2006, 8:1249-1252.
97. Gonzalez-Zulueta M., Ensz L.M., Mukhina G., Lebovitz R.M., Zwacka R.M., Engelhardt J.F., Oberley L.W., Dawson V.L., Dawson T.M. Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J. Neurosci. 1998, 18:2040-2055.
98. Gough D.R., Cotter T.G. Hydrogen peroxide: a Jekyll and Hyde signalling molecule. Cell Death Dis. 2011, 2.
99. Graziewicz M.A., Day B.J., Copeland W.C. The mitochondrial DNA polymerase as a target of oxidative damage. Nucleic Acids Res. 2002, 30:2817-2824.
100. Gregory E.M., Fridovich I. Oxygen toxicity and the superoxide dismutase. J. Bacteriol. 1973, 114:1193-1197.
101. Gregory E.M., Goscin S.A., Fridovich I. Superoxide dismutase and oxygen toxicity in a eukaryote. J. Bacteriol. 1974, 117:456-460.
102. Grivennikova V.G., Vinogradov A.D. Generation of superoxide by the mitochondrial Complex I. Biochim. Biophys. Acta 2006, 1757:553-561.
103. Guzy R.D., Hoyos B., Robin E., Chen H., Liu L., Mansfield K.D., Simon M.C., Hammerling U., Schumacker P.T. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 2005, 1:401-408.
104. Hainaut P., Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 1993, 53:4469-4473.
105. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 2007, Oxford University Press, New York. 4th ed.
106. Han D., Williams E., Cadenas E. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem. J. 2001, 353:411-416.
107. Han D., Canali R., Garcia J., Aguilera R., Gallaher T.K., Cadenas E. Sites and mechanisms of aconitase inactivation by peroxynitrite: modulation by citrate and glutathione. Biochemistry 2005, 44:11986-11996.
108. Hanukoglu I. Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug Metab. Rev. 2006, 38:171-196.
109. Hanukoglu I., Rapoport R., Weiner L., Sklan D. Electron leakage from the mitochondrial NADPH-adrenodoxin reductase-adrenodoxin-P450scc (cholesterol side chain cleavage) system. Arch. Biochem. Biophys. 1993, 305:489-498.
110. Hausladen A., Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J. Biol. Chem. 1994, 269:29405-29408.
111. Hempel N., Carrico P.M., Melendez J.A. Manganese superoxide dismutase (Sod2) and redox-control of signaling events that drive metastasis. Anticancer Agents Med Chem. 2011, 11:191-201.
112. Herrero A., Barja G. Localization of the site of oxygen radical generation inside the complex I of heart and nonsynaptic brain mammalian mitochondria. J. Bioenerg. Biomembr. 2000, 32:609-615.
113. Hirschhaeuser F., Sattler U.G.A., Mueller-Klieser W. Lactate: a metabolic key player in cancer. Cancer Res. 2011, 71:6921-6925.
114. Hjalmarsson K., Marklund S.L., Engstrom A., Edlund T. Isolation and sequence of complimentary DNA encoding human extracellular superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:6340-6344.
115. Ho J.C.-m., Zheng S., Comhair S.A.A., Farver C., Erzurum S.C. Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res. 2001, 61:8578-8585.
116. Holley A.K., Kiningham K.K., Spitz D.R., Edwards D.P., Jenkins J.T., Moore M.R. Progestin stimulation of manganese superoxide dismutase and invasive properties in T47D human breast cancer cells. J. Steroid Biochem. Mol. Biol. 2009, 117:23-30.
117. Holley A.K., Bakthavatchalu V., Velez-Roman J.M., St.Clair D.K. Manganese superoxide dismutase: guardian of the powerhouse. Int. J. Mol. Sci. 2011, 12.
118. Hoye A.T., Davoren J.E., Wipf P., Fink M.P., Kagan V.E. Targeting mitochondria. Acc. Chem. Res. 2008, 41:87-97.
119. Hu Y., Rosen D.G., Zhou Y., Feng L., Yang G., Liu J., Huang P. Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress. J. Biol. Chem. 2005, 280:39485-39492.
120. Hu H., Luo M.-l., Du X.-l, Feng Y.-b, Zhang Y., Shen X.-m, Xu X., Cai Y., Han Y.-l, Wang M.-R. Up-regulated manganese superoxide dismutase expression increases apoptosis resistance in human esophageal squamous cell carcinomas. Chin. Med. J. 2007, 120:2092-2098.
121. Huang T.-T., Carlson E.J., Kozy H.M., Mantha S., Goodman S.I., Ursell P.C., Epstein C.J. Genetic modification of prenatal lethality and dilated cardiomyopathy in Mn superoxide dismutase mutant mice. Free Radic. Biol. Med. 2001, 31:1101-1110.
122. Huie R.E., Padmaja S. The reaction of NO with superoxide. Free Radic. Res. Commun. 1993, 18:195-199.
123. Hussain S.P., Amstad P., He P., Robles A., Lupold S., Kaneko I., Ichimiya M., Sengupta S., Mechanic L., Okamura S., Hofseth L.J., Moake M., Nagashima M., Forrester K.S., Harris C.C. p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res. 2004, 64:2350-2356.
124. Iborra F.J., Kimura H., Cook P.R. The functional organization of mitochondrial genomes in human cells. BMC Biol. 2004, 2:9-22.
125. Ikegami T., Suzuki Y.-i., Shimizu T., Isono K.-i, Koseki H., Shirasawa T. Model mice for tissue-specific deletion of the manganese superoxide dismutase (MnSOD) gene. Biochem. Biophys. Res. Commun. 2002, 296:729-736.
126. Inagaki M., Yoshikawa E., Matsuoka Y., Sugawara Y., Nakano T., Akechi T., Wada N., Imoto S., Murakami K., Uchitomi Y. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 2007, 109:146-156. the Breast Cancer Survivors' Brain MRI Database Group.
127. Indo H.P., Davidson M., Yen H.-C., Suenaga S., Tomita K., Nishii T., Higuchi M., Koga Y., Ozawa T., Majima H.J. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion 2007, 7:106-118.
128. Ishikawa K., Takenaga K., Akimoto M., Koshikawa N., Yamaguchi A., Imanishi H., Nakada K., Honma Y., Hayashi J.-I. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008, 320:661-664.
129. Izutani R., Asano S., Imano M., Kuroda D., Kato M., Ohyanagi H. Expression of manganese superoxide dismutase in esophageal and gastric cancers. J. Gastroenterol. 1998, 33:816-822.
130. Jandova J., Shi M., Norman K.G., Stricklin G.P., Sligh J.E. Somatic alterations in mitochondrial DNA produce changes in cell growth and metabolism supporting a tumorigenic phenotype. Biochim. Biophys. Acta 2012, 1822:293-300.
131. Jang Y.C., Perez V.I., Song W., Lustgarten M.S., Salmon A.B., Mele J., Qi W., Liu Y., Liang H., Chaudhuri A., Ikeno Y., Epstein C.J., Van Remmen H., Richardson A. Overexpression of Mn superoxide dismutase does not increase life span in mice. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64A:1114-1125.
132. Janssen A.M.L., Bosman C.B., van Duijn W., Oostendorp-van de Ruit M.M., Kubben F.J.G.M., Griffioen G., Lamers B.B.H.W., van Krieken J.H.J.M., van de Velde C.J.H., Verspaget H.W. Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Clin. Cancer Res. 2000, 6:3183-3192.
133. Jiang B.-H., Rue E., Wang G.L., Roe R., Semenza G.L. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 1996, 271:17771-17778.
134. 2 tension. Am. J. Physiol. Cell Physiol. 1996, 271:C1172-C1180.
135. Joshi G., Sultana R., Tangpong J., Cole M.P., St.Clair D.K., Vore M., Estus S., Butterfield D.A. Free radical mediated oxidative stress and toxic side effects in brain induced by the anticancer drug adriamycin: insight into chemobrain. Free Radic. Res. 2005, 29:1147-1154.
136. Kabe Y., Ando K., Hirao S., Yoshida M., Handa H. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid. Redox Signal. 2005, 7:395-403.
137. Kaewpila S., Venkataraman S., Buettner G.R., Oberley L.W. Manganese superoxide dismutase modulates hypoxia-inducible factor-1α induction via superoxide. Cancer Res. 2008, 68:2781-2788.
138. Kang D., Hamasaki N. Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer. Curr. Med. Chem. 2005, 12:429-441.
139. Kang Y.J., Sun X., Chen Y., Zhou Z. Inhibition of doxorubicin chronic toxicity in catalase-overexpressing transgenic mouse hearts. Chem. Res. Toxicol. 2002, 15:1-6.
140. Kattan Z., Minig V., Leroy P., Dauca M., Becuwe P. Role of manganese superoxide dismtuase on growth and invasive properties of human estrogen-independent breast cancer cells. Breast Cancer Res. Treat. 2008, 108:203-215.
141. Kawauchi K., Araki K., Tobiume K., Tanaka N. p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nat. Cell Biol. 2008, 10:611-618.
142. Kawauchi K., Araki K., Tobiume K., Tanaka N. Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3431-3436.
143. Ke Q., Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 2006, 70:1469-1480.
144. Keele B.B., McCord J.M., Fridovich I. Further characterization of bovine superoxide dismutase and its isolation from bovine heart. J. Biol. Chem. 1971, 246:2875-2880.
145. Keller J.N., Kindy M.S., Holtsberg F.W., St.Clair D.K., Yen H.-C., Germeyer A., Steiner S.M., Bruce-Keller A.J., Hutchins J.B., Mattson M.P. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 1998, 18:687-697.
146. Kelner M.J., Montoya M.A. Structural organization of the human glutathione reductase gene: determination of correct cDNA sequence and identification of a mitochondrial leader sequence. Biochem. Biophys. Res. Commun. 2000, 269:366-368.
147. Kienhofer J., Haussler D.J.F., Ruckelshausen F., Muessig E., Weber K., Pimentel D., Ullrich V., Burkle A., Bachschmid M.M. Association of mitochondrial antioxidant enzymes with mitochondrial DNA as integral nucleoid constitutents. FASEB J. 2009, 23:2034-2044.
148. Kim J.-w., Tchernyshyov I., Semenza G.L., Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006, 3:177-185.
149. Kim A., Che C.-H., Ursell P.C., Huang T.-T. Genetic modifier of mitochondrial superoxide dismutase-deficient mice delays heart failure and prolongs survival. Mamm. Genome 2010, 21:534-542.
150. Kim H.-S., Patel K., Muldoon-Jacobs K., Bisht K.S., Aykin-Burns N., Pennington J.D., van der Meer R., Nguyen P., Savage J., Owens K.M., Vassilopoulos A., Ozden O., Park S.-H., Singh K.K., Abdulkadir S.A., Spitz D.R., Deng C.-X., Gius D. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010, 17:41-52.
151. Kiningham K.K., St.Clair D.K. Overexpression of manganese superoxide dismutase selectively modulates the activity of Jun-associated transcription factors in fibrosarcoma cells. Cancer Res. 1997, 57:5265-5271.
152. Klimova T., Chandel N.S. Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ. 2008, 15:660-666.
153. Koehler C.M., Beverley K.N., Leverich E.P. Redox pathways of the mitochondrion. Antioxid. Redox Signal. 2006, 8:813-822.
154. Kokoszka J.E., Coskun P., Esposito L.A., Wallace D.C. Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc. Natl. Acad. Sci. 2001, 98:2278-2283.
155. Kondoh H., Lleonart M.E., Gil J., Wang J., Degan P., Peters G., Martinez D., Carnero A., Beach D. Glycolytic enzymes can modulate cellular life span. Cancer Res. 2005, 65:177-185.
156. Koppenol W.H., Bounds P.L., Dang C.V. Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 2011, 11:325-337.
157. + oxidation-reduction state. Biochem. J. 2002, 368:545-553.
158. Landriscina M., Remiddi F., Ria F., Palazzotti B., De Leo M.E., Iacoangeli M., Rosselli R., Scerrati M., Galeotti T. The level of MnSOD is directly correlated with grade of brain tumours of neuroepithelial origin. Br. J. Cancer 1996, 74:1877-1885.
159. Lane D.P. p53, guardian of the genome. Nature 1992, 358:15-16.
160. Larosche I., Letteron P., Berson A., Fromenty B., Huang T.-T., Moreau R., Pessayre D., Mansouri A. Hepatic mitochondrial DNA depletion after an alcohol binge in mice: probable role of peroxynitrite and modulation by manganese superoxide dismutase. J. Pharmacol. Exp. Ther. 2010, 332:886-897.
161. Lebedeva M.A., Eaton J.S., Shadel G. Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis. Biochim. Biophys. Acta 2009, 1787:328-334.
162. Lebovitz R.M., Zhang H., Vogel H., Cartwright J., Dionne L., Lu N., Huang S., Matzuk M.M. Neurodegeneration, mycardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:9782-9787.
163. Lee S.-R., Kim J.-R., Kwon K.-S., Yoon H.W., Levine R.L., Ginsburg A., Rhee S.G. Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver. J. Biol. Chem. 1999, 274:4722-4734.
164. Legros F., Malka F., Frachon P., Lombes A., Rojo M. Organization and dynamics of human mitochondrial DNA. J. Cell Sci. 2004, 117:2653-2662.
165. Lenaz G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 2001, 52:159-164.
166. Levine A.J., Puzio-Kuter A.M. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010, 330:1340-1344.
167. Li Y., Huang T.-T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., Noble L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C., Epstein C.J. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 1995, 11.
168. Li N., Oberley T.D., Oberley L.W., Zhong W. Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has mutliple effects on cell phenotype. Prostate 1998, 35:221-233.
169. Li S., Yan T., Yang J.-Q., Oberley T.D., Oberley L.W. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res. 2000, 60:3927-3939.
170. -/+ mice. Free Radic. Biol. Med. 2004, 36:542-554.
171. Liu R., Oberley T.D., Oberley L.W. Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral sqamous carcinoma SCC-25 cells. Hum. Gene Ther. 1997, 8:585-595.
172. Liu B., Chen Y., St Clair D.K. ROS and p53: a versatile partnership. Free Radic. Biol. Med. 2008, 44:1529-1535.
173. Liu J., St.Clair D.K., Gu X., Zhao Y. Blocking mitochondrial permeability transition prevents p53 mitochondrial translocation during skin tumor promotion. FEBS Lett. 2008, 582:1319-1324.
174. Liu Y., Borchert G.L., Donald S.P., Diwan B.A., Anver M., Phang J.M. Proline oxidase functions as a mitochondrial tumor suppressor in human cancers. Cancer Res. 2009, 69:6414-6422.
175. Loch T., Vakhrusheva O., Piotrowska I., Ziolkowski W., Ebelt H., Braun T., Bober E. Different extent of cardiac malfunction and resistance to oxidative stress in heterozygous and homozygous manganese-dependent superoxide dismutase-mutant mice. Cardiovasc. Res. 2009, 82:448-457.
176. Longo V.D., Liou L.-L., Valentine J.S., Gralla E.B. Mitochondrial superoxide decreases yeast survival in stationary phase. Arch. Biochem. Biophys. 1999, 365:131-142.
177. Lopez-Lazaro M. The Warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?. Anticancer Agents Med Chem. 2008, 8:305-312.
178. Lu J., Sharma L.K., Bai Y. Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res. 2009, 19:802-815.
179. Lustgarten M.S., Jang Y.C., Liu Y., Muller F.L., Qi W., Steinhelper M., Brooks S.V., Larkin L., Shimizu T., Shirasawa T., McManus L.M., Bhattacharya A., Richardson A., Van Remmen H. Conditional knockout of Mn-SOD targeted to type IIB skeletal muscle fibers increases oxidative stress and is sufficient to alter aerobic exercise capacity. Am. J. Physiol. Cell Physiol. 2009, 297:C1520-C1532.
180. Lustgarten M.S., Jang Y.C., Liu Y., Qi W., Qin Y., Dahia P.L., Shi Y., Bhattacharya A., Muller F.L., Shimizu T., Shirasawa T., Richardson A., Van Remmen H. MnSOD deficiency results in elevated oxidative stress and decreased mitochondrial function but does not lead to muscle atrophy during aging. Aging Cell 2011, 10:493-505.
181. MacMillan-Crow L.A., Crow J.P., Kerby J.D., Beckman J.S., Thompson J.A. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:11853-11858.
182. MacMillan-Crow L.A., Crow J.P., Thompson J.A. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 1998, 37:1613-1622.
183. Madan E., Gogna R., Bhatt M., Pati U., Kuppusamy P., Mahdi A.A. Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor. Oncotarget 2011, 2:948-957.
184. Madsen-Bouterse S.A., Zhong Q., Mohammad G., Ho Y.-S., Kowluru R.A. Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase. Free Radic. Res. 2010, 44:313-321.
185. Maiorino M., Scapin M., Ursini F., Biasolo M., Bosello V., Flohe L. Distinct promoters determine alternative transcription of gpx-4 into phospholipid-hydroperoxide glutathione peroxidase variants. J. Biol. Chem. 2003, 278:34286-34290.
186. Malafa M., Margenthaler J., Webb B., Neitzel L., Christophersen M. MnSOD expression is increased in metastatic gastric cancer. J. Surg. Res. 2000, 88:130-134.
187. Mambo E., Gao X., Cohen Y., Guo Z., Talalay P., Sidransky D. Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homplasmic mutations. Proc. Natl. Acad. Sci. 2003, 100:1838-1843.
188. Mansouri A., Muller F.L., Liu Y., Ng R., Faulkner J., Hamilton M., Richardson A., Huang T.-T., Epstein C.J., Van Remmen H. Alterations in mitochondrial function, hydrogen peroxide release and oxidative damage in mouse hind-limb skeletal muscle during aging. Mech. Ageing Dev. 2006, 127:298-306.
189. Mansouri A., Tarhuni A., Larosche I., Reyl-Desmars F., Demeilliers C., Degoul F., Nahon P., Sutton A., Moreau R., Fromenty B., Ressayre D. MnSOD overexpression prevents liver mitochondrial DNA depletion after an alcohol binge but worsens this effect after prolonged alcohol consumption in mice. Dig. Dis. 2010, 28:756-775.
190. Martin F.M., Xu X., von Lohneysen K., Gilmartin T.J., Friedman J. SOD2 deficient erythroid cells up-regulate transferrin receptor and down-regulate mitochondrial biogenesis and metabolism. PLoS One 2011, 6:e16894.
191. Matoba S., Kang J.G., Patino W.D., Wragg A., Boehm M., Gavrilova O., Hurley P.J., Bunz F., Hwang P.M. p53 regulates mitochondrial respiration. Science 2006, 312:1650-1653.
192. McCord J.M., Fridovich I. Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 1969, 244:6049-6055.
193. McLennan H.R., Degli Esposti M. The contribution fo mitochondrial respiratory complexes to the production of reactive oxygen species. J. Bioenerg. Biomembr. 2000, 32:153-162.
194. Melov S., Schneider J.A., Day B.J., Hinerfeld D., Coskun P., Mirra S.S., Crapo J.D., Wallace D.C. A novel neurological phenotype in mice lacking mitochondrial manganese sueproxide dismutase. Nat. Genet. 1998, 18:159-163.
195. Melov S., Coskun P., Patel M., Tuinstra R., Cottrell B.A., Jun A.S., Zastawny T.H., Dizdaroglu M., Goodman S.I., Huang T.-T., Miziorko H., Epstein C.J., Wallace D.C. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. 1999, 96:846-851.
196. Miao L., St.Clair D.K. Regulation of superoxide dismutase genes: implications in disease. Free Radic. Biol. Med. 2009, 47:344-356.
197. Michishita E., Park J.Y., Burneskis J.M., Barrett J.C., Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell 2005, 16:4623-4635.
198. Minotti G., Menna P., Salvatorelli E., Cairo G., Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 2004, 56:185-229.
199. Misawa H., Nakata K., Matsuura J., Moriwaki Y., Kawashima K., Shimizu T., Shirawawa T., Takahashi R. Conditional knockout of Mn superoxide dismutase in postnatal motor neurons reveals resistance to mitochondrial generated superoxide radicals. Neurobiol. Dis. 2006, 23:169-177.
200. Miwa S., St.-Pierre J., Partridge L., Brand M.D. Superoxide and hydrogen peroxide production by Drosophila mitochondria. Free Radic. Biol. Med. 2003, 35:938-948.
201. Mohr A., Buneker C., Gough R.P., Zwacka R.M. MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release. Oncogene 2008, 27:763-774.
202. Moreno-Sanchez R., Rodriguez-Enriquez S., Marin-Hernandez A., Saavedra E. Energy metabolism in tumor cells. FEBS J. 2007, 274:1393-1418.
203. Morgan M.J., Lehmann M., Schwarzlander M., Baxter C.J., Sienkiewicz-Porzucek A., Williams T.C.R., Schauer N., Fernie A.R., Fricker M.D., Ratcliffe R.G., Sweetlove L.J., Finkemeier I. Decrease in manganese superoxide dismutase leads to reduced root growth and affects tricarboxylic acid cycle flux and mitochondrial redox homeostasis. Plant Physiol. 2008, 147:101-114.
204. Mukherjee S., Forde R., Belton A., Duttaroy A. SOD2, the principal scavenger of mitochondrial superoxide, is dispensable for embryogenesis and imaginal tissue development but essential for adult survival. Fly 2011, 5:39-46.
205. Muller F.L., Liu Y., Van Remmen H. Complex III releases superoxide to both sides of the inner mitochondrial membrane. J. Biol. Chem. 2004, 279:49064-49073.
206. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417:1-13.
207. Murray J., Taylors S.W., Zhang B., Ghosh S.S., Capaldi R.A. Oxidative damage to mitochondrial complex I due to peroxynitrite. Identification of reactive tyrosines by mass spectrometry. J. Biol. Chem. 2003, 278:37223-37230.
208. Nelson K.K., Ranganathan A.C., Mansouri J., Rodriguez A.M., Providence K.M., Rutter J.L., Pumiglia K., Bennett J.A., Melendez J.A. Elevated Sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin. Cancer Res. 2003, 9:424-432.
209. Nelson C.J., Nandy N., Roth A.J. Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliat. Support. Care 2007, 5:273-280.
210. Nithipongvanitch R., Ittarat W., Velez J.M., Zhao R., St.Clair D.K., Oberley T.D. Evidence for p53 as guardian of the cardiomyocyte mitochondrial genome following acute adriamycin treatment. J. Histochem. Cytochem. 2007, 55:629-639.
211. Nozoe T., Honda M., Inutsuka S., Yasuda M., Korenaga D. Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma. Oncol. Rep. 2003, 10:39-43.
212. Oberley L.W. Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed. Pharmacother. 2005, 59:143-148.
213. Oberley L.W., Buettner G.R. Role of superoxide dismutase in cancer: a review. Cancer Res. 1979, 39:1141-1149.
214. Oberley T.D., Verwiebe E., Zhong W., Kang S.W., Rhee S.G. Localization of the thioredoxin system in normal rat kidney. Free Radic. Biol. Med. 2001, 30:412-424.
215. Ohnishi T. Thermodynamic and EPR characterization of iron-sulfur centers in the NADH-ubiquinone segment of the mitochondrial respiratory chain in pigeon heart. Biochim. Biophys. Acta 1975, 387:475-490.
216. Ohnishi T. Iron-sulfur clusters/semiquinones in complex I. Biochim. Biophys. Acta 1998, 1364:186-206.
217. Ohnishi T., Tamai I., Sakanaka K., Sakata A., Yamashima T., Yamashita J., Tsuji A. In vivo and in vitro evidence for ATP-dependency of p-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier. Biochem. Pharmacol. 1995, 49:1541-1544.
218. Okado-Matsumoto A., Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver. Cu, Zn-SOD in mitochondria. J. Biol. Chem. 2001, 276:38388-38393.
219. Okamura S., Ng C.C., Koyama K., Takei Y., Arakawa H., Monden M., Nakamura Y. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system. Oncol. Res. 1999, 11:281-285.
220. Ornoy A. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy. Reprod. Toxicol. 2007, 24:31-41.
221. Ozden O., Park S.-H., Kim H.-S., Jiang H., Coleman M.C., Spitz D.R., Gius D. Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative stress. Aging 2011, 3:102-107.
222. Padmaja S., Squadrito G.L., Pryor W.A. Inactivation of glutathione peroxidase by peroxynitrite. Arch. Biochem. Biophys. 1998, 349:1-6.
223. Palazzotti B., Pani G., Colavitti R., de Leo M.E., Bedogni B., Borrello S., Galeotti T. Increased growth capacity of cervical-carcinoma cells over-expressing manganous superoxide dismutase. Int. J. Cancer 1999, 82:145-150.
224. Pallotti F., Baracca A., Hernandez-Rosa E., Walker W.F., Solaini G., Lenaz G., Melzi d'Eril G.V., DiMauro S., Schone E.A., Davidson M.M. Biochemical analysis of respiratory function in cybrid cell lines harbouring mitochondrial DNA mutations. Biochem. J. 2004, 384:287-293.
225. Panfili E., Sandri G., Ernster L. Distribution of glutathione peroxidases and glutathione reductase in rat brain mitochondria. FEBS Lett. 1991, 290:35-37.
226. Pani G., Galeotti T., Chiarugi P. Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev. 2010, 29:351-378.
227. Papandreou I., Cairns R.A., Fontana L., Lim A.L., Denko N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006, 3:187-197.
228. Parajuli N., Marine A., Simmons S., Saba H., Mitchell T., Shimizu T., Shirasawa T., MacMillan-Crow L.A. Generation and characterization of a novel kidney-specific manganese superoxide dismutase knockout mouse. Free Radic. Biol. Med. 2011, 51:406-416.
229. Park S.Y., Chang I., Kim J.-Y., Kang S.W., Park S.-H., Singh K., Lee M.-S. Resistance of mitochondrial DNA-depleted cells against cell death: role of mitochondrial superoxide dismutase. J. Biol. Chem. 2004, 279:7512-7520.
230. Park J.S., Sharma L.K., Li H., Xiang R., Holstein D., Wu J., Lechleiter J., Naylor S.L., Deng J.J., Lu J., Bai Y. A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. Hum. Mol. Genet. 2009, 18:1578-1589.
231. Park J.Y., Wang P.Y., Matsumoto T., Sung H.J., Ma W., Choi J.W., Anderson S.A., Leary S.C., Balaban R.S., Kang J.G., Hwang P.M. p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content. Circ. Res. 2009, 105:705-712. (711 p following 712).
232. Patten D.A., Lafleur V.N., Robitaille G.A., Chan D.A., Giaccia A.J., Richard D.E. Hypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species. Mol. Biol. Cell 2010, 21:3247-3257.
233. Paul A., Belton A., Nag S., Martin I., Grotewiel M.S., Duttaroy A. Reduced mitochondrial SOD displays mortality characteristics reminiscent of natural aging. Mech. Ageing Dev. 2007, 128:706-716.
234. Pearce L.L., Epperly M.W., Greenberger J.S., Pitt B.R., Peterson J. Identification of respiratory complexes I and III as mitochondrial sites of damage following exposure to ionizing radiation and nitric oxide. Nitric Oxide 2001, 5:128-136.
235. Pelicano H., Xu R.-h., Du M., Feng L., Sasaki R., Carew J.S., Hu Y., Ramdas L., Hu L., Keating M.J., Zhang W., Plunkett W., Huang P. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J. Cell Biol. 2006, 175:913-923.
236. Perez V.I., Van Remmen H., Bokov A., Epstein C.J., Vijg J., Richardson A. The overexpression of major antioxidant enzymes does not extend the lifespan of mice. Aging Cell 2009, 8:73-75.
237. Petros J.A., Baumann A.K., Ruiz-Pesini E., Amin M.B., Sun C.Q., Hall J., Lim S., Issa M.M., Flanders W.D., Hosseini S.H., Marshall F.F., Wallace D.C. mtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl. Acad. Sci. 2005, 102:719-724.
238. Poli G., Leonarduzzi G., Biasi F., Chiarpotto E. Oxidative stress and cell signaling. Curr. Med. Chem. 2004, 11:1163-1182.
239. Powell C.S., Jackson R.M. Mitochondrial complex I, aconitase, and succinate dehydrogenase during hypoxia-reoxygenation: modulation of enzyme activities by MnSOD. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:L189-L198.
240. Powis G., Kirkpatrick D.L. Thioredoxin signaling as a target for cancer therapy. Curr. Opin. Pharmacol. 2007, 7:392-397.
241. Quiros I., Sainz R.M., Hevia D., Garcia-Suarez O., Astudillo A., Rivas M., Mayo J.C. Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells. Int. J. Cancer 2009, 125:1497-1504.
242. Quiros-Gonzalez I., Sainz R.M., Hevia D., Mayo J.C. MnSOD drives neuroendocrine differentiation, androgen independence, and cell survival in prostate cancer cells. Free Radic. Biol. Med. 2011, 50:525-536.
243. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 1991, 266:4244-4250.
244. Radi R., Turrens J.F., Chang L.Y., Bush K.M., Crapo J.D., Freeman B.A. Detection of catalase in rat heart mitochondria. J. Biol. Chem. 1991, 266:22028-22034.
245. Radi R., Rodriquez M., Castro L., Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. 1994, 308:89-95.
246. Radi R., Cassina A., Hodara R., Quijano C., Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic. Biol. Med. 2002, 33:1451-1464.
247. Raha S., Robinson B.H. Mitochondria, oxygen free radicals, disease, and ageing. TIBS 2000, 25:502-508.
248. Raha S., Robinson B.H. Mitochondria, oxygen free radicals, and apoptosis. Am. J. Med. Genet. C Semin. Med. Genet. 2001, 106:62-70.
249. 2-dependent ERK1/2 activation. J. Biol. Chem. 2001, 276:14264-14270.
250. Ravindranath S.D., Fridovich I. Isolation and characterization of a manganese-containing superoxide dismutase from yeast. J. Biol. Chem. 1975, 250:6107-6112.
251. Rhee S.G., Chang T.-S., Bae Y.S., Lee S.-R., Kang S.W. Cellular regulation by hydrogen peroxide. J. Am. Soc. Nephrol. 2003, 14:S211-S215.
252. Richter C., Park J.-W., Ames B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:6465-6467.
253. Ridnour L.A., Oberley T.D., Oberley L.W. Tumor suppressive effects of MnSOD overexpression may involve imbalance in peroxide generation versus peroxide removal. Antioxid. Redox Signal. 2004, 6:501-512.
254. Riobo N.A., Clementi E., Melani M., Boveris A., Cadenas E., Moncada S., Poderoso J.J. Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation. Biochem. J. 2001, 359:139-145.
255. Robey I.F., Lien A.D., Welsh S.J., Baggett B.K., Gillies R.J. Hypoxia-inducible factor-1α and the glycolytic phenotype in tumors. Neoplasia 2005, 7:324-330.
256. Roessler M.M., King M.S., Robinson A.j., Armstrong F.A., Harmer J., Hirst J. Direct assignment of EPR spectra to structurally defined iron-sulfur clusters in complex i by double electron-electron resonance. Proc. Natl. Acad. Sci. 2010, 107:1930-1935.
257. Rotig A., de Lonlay P., Chretien D., Foury F., Koenig M., Sidi D., Munnich A., Rustin P. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat. Genet. 1997, 17:215-217.
258. Sablina A.A., Budanov A.V., Ilyinskaya G.V., Agapova L.S., Kravchenko J.E., Chumakov P.M. The antioxidant function of the p53 tumor suppressor. Nat. Med. 2005, 11:1306-1313.
259. Safford S.E., Oberley T.D., Urano M., St.Clair D.K. Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase. Cancer Res. 1994, 54:4261-4265.
260. Salvi M., Battaglia V., Brunati A.M., La Rocca N., Tibaldi E., Pietrangeli P., Marcocci L., Mondovi B., Rossi C.A., Toninello A. Catalase takes part in rat liver mitochondria oxidative stress defense. J. Biol. Chem. 2007, 282:24407-24415.
261. Salzman R., Kankova K., Pacal L., Tomandl J., Horakova Z., Kostrica R. Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases. Neoplasma 2007, 54:321-325.
262. Sarvazyan N. Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 1996, 271:H2079-H2085.
263. Sasabe E., Yang Z., Ohno S., Yamamoto T. Reactive oxygen species produced by the knockdown of manganese-superoxide dismutase up-regulate hypoxia-inducible factor-1α expression in oral squamous cell carcinoma cells. Free Radic. Biol. Med. 2010, 48:1321-1329.
264. Schafer M., Schafer C., Ewald N., Piper H.M., Noll T. Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia. Circ. Res. 2003, 92:1010-1015.
265. Schwartzenberg-Bar-Yoseph F., Armoni M., Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004, 64:2627-2633.
266. Seigers R., Fardell J.E. Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci. Biobehav. Rev. 2011, 35:729-741.
267. Semenza G.L. HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J. Bioenerg. Biomembr. 2007, 39:231-234.
268. Semenza G.L. HIF-1: upstream and downstream of cancer metabolism. Curr. Opin. Genet. Dev. 2010, 20:51-56.
269. Semenza G.L. Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb. Symp. Quant. Biol. 2011, 76.
270. Semenza G.L., Jiang B.-H., Leung S.W., Passantino R., Concordet J.-P., Maire P., Giallongo A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential bindign sites for hypoxia-inducible factor 1. J. Biol. Chem. 1996, 271:32529-32537.
271. Seo M.S., Kang S.W., Kim K., Baines I.C., Lee T.H., Rhee S.G. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J. Biol. Chem. 2000, 275:20346-20354.
272. Shanware N.P., Mullen A.R., DeBerardinis R.J., Abraham R.T. Glutamine: pleiotropic roles in tumor growth and stress resistance. J. Mol. Med. 2011, 89:229-236.
273. Shen L., Fang H., Chen T., He J., Zhang M., Wei X., Xin Y., Jiang Y., Ding Z., Ji J., Lu J., Bai Y. Evaluating mitochondrial DNA in cancer occurrence and development. Ann. N. Y. Acad. Sci. 2010, 1201:26-33.
274. Shi D.-y., Xie F.-z, Zhai C., Stern J.S., Liu Y., Liu S.-l The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells. Mol. Cancer 2009, 8:32.
275. Shibata E., Nanri H., Ejima K., Araki M., Fukuda J., Yoshimura K., Toki N., Ikeda M., M., K. Enhancement of mitochondrial oxidative stress and up-regulation of antioxidant protein peroxiredoxin III/SP-22 in the mitochondria of human pre-eclamptic placentae. Placenta 2003, 24:698-705.
276. Shioji K., Kishimoto C., Nakamura H., Masutani H., Yuan Z., Oka S.-i., Yodoi J. Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation 2002, 106:1403-1409.
277. Short K.R., Bigelow M.L., Kahl J., Singh R., Coenen-Schimke J., Raghavakaimal S., Nair K.S. Decline in skeletal muscle mitochondrial function with aging in humans. Proc. Natl. Acad. Sci. 2005, 102:5618-5623.
278. Silverman D.H.S., Dy C.J., Castellon S.A., Lai J., Pio B.S., Abraham L., Waddell K., Petersen L., Phelps M.E., Ganz P.A. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res. Treat. 2007, 103:303-311.
279. Simbre V.C., Duffy S.a., Dadlani G.H., Miller T.L., Lipshultz S.E. Cardiotoxicity of cancer chemotherapy. Implications for children. Paediatr. Drugs 2005, 7:187-202.
280. Soini Y., Vakkala M., Kahlos K., Paakko P., Kinnla V. MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells. J. Pathol. 2001, 195:156-162.
281. Squadrito G.L., Pryor W.A. The formation of peroxynitrite in vivo from nitric oxide and superoxide. Chem. Biol. Interact. 1995, 96:203-206.
282. St.Clair D.K., Wan X.S., Oberley T.D., Muse K.E., St.Clair W.H. Suppression of radiation-induced neoplastic transformation by overexpression of mitochondrial superoxide dismutase. Mol. Carcinog. 1992, 6:238-242.
283. Stambolsky P., Weisz L., Shats I., Klein Y., Goldfinger N., Oren M., Rotter V. Regulation of AIF expression by p53. Cell Death Differ. 2006, 13:2140-2149.
284. Starkov A.A., Fiskum G., Chinopoulos C., Lorenzo B.J., Browne S.E., Patel M.S., Beal M.F. Mitochondrial α-ketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci. 2004, 24:7779-7788.
285. Steinman H.M., Weinstein L., Brenowitz M. The manganese superoxide dismutase of Escherichia coli K-12 associates with DNA. J. Biol. Chem. 1994, 269:28629-28634.
286. Storz P. Reactive oxygen species in tumor progression. Front. Biosci. 2005, 10:1881-1896.
287. Stubbs M., Griffiths J.R. The altered metabolism of tumors: HIF-1 and its role in the Warburg effect. Adv. Enzyme Regul. 2010, 50:44-55.
288. Sullivan P.G., Bruce-Keller A.J., Rabchevsky A.G., Cristakos S., Clair D.K., Mattson M.P., Scheff S.W. Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J. Neurosci. 1999, 19:6248-6256.
289. Sun X., Zhou Z., Kang Y.J. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart. Cancer Res. 2001, 61:3382-3387.
290. Sun J., Folk D., Bradley T.J., Tower J. Induced overexpression of mitochondrial Mn-superoxide dismutase extends the life span of adult Drosophila melanogaster. Genetics 2002, 161:661-672.
291. Sun X., Vinci C., Makmura L., Han S., Tran D., Nguyen J., Hamann M., Grazziani S., Sheppard S., Gutova M., Zhou F., Thomas J., Momand J. Formation of disulfide bond in p53 correlates with inhibition of DNA binding and tetramerization. Antioxid. Redox Signal. 2003, 5:655-665.
292. Sun W., Zhou S., Chang S.S., McFate T., Verma A., Califano J.A. Mitochondrial mutations contribute to HIF1α accumulation via increased reactive oxygen species and up-regulated pyruvate dehydrogenase kinase 2 in head and neck squamous cell carcinoma. Clin. Cancer Res. 2009, 15:476-484.
293. Takai D., Park S.-H., Takada Y., Ichinose S., Kitagawa M., Akashi M. UV-irradiation induces oxidative damage to mitochondrial DNA primarily through hydrogen peroxide: analysis of 8-oxodGuo by HPLC. Free Radic. Res. 2006, 40:1138-1148.
294. Takeshige K., Minakami S. NADH- and NADPH-dependent formation of superoxide anions by bovine heart submitochondrial particles and NADH-ubiquinone reductase preparation. Biochem. J. 1979, 180:129-135.
295. Tanaka M., Kovalenko S.A., Gong J.-S., Borgeld H.-J.W., Katsumata K., Hayakawa M., Yoneda M., Ozawa T. Accumulation of deletions and point mutations in mitochondrial genome in degenerative diseases. Ann. N. Y. Acad. Sci. 1996, 102-111.
296. Tangpong J., Cole M.P., Sultana R., Joshi G., Estus S., Vore M., St.Clair W., Ratanachaiyavong S., St.Clair D.K., Butterfield D.A. Adriamycin-induced, TNF-α-mediated central nervous system toxicity. Neurobiol. Dis. 2006, 23:127-139.
297. Tangpong J., Cole M.P., Sultana R., Estus S., Vore M., St.Clair W., Ratanachaiyavong S., St.Clair D.K., Butterfield D.A. Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain. J. Neurochem. 2007, 100:191-201.
298. Tannock I.F., Ahles T.A., Ganz P.A., van Dam F.S. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J. Clin. Oncol. 2004, 22:2233-2239.
299. Tao R., Coleman M.C., Pennington J.D., Ozden O., Park S.-H., Jiang H., Kim H.-S., Flynn C.R., Hill S., McDonald W.H., Olivier A.K., Spitz D.R., Gius D. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol. Cell 2010, 40:893-904.
300. 1 complex). Precursor proteins and their transfer into mitochondria. J. Biol. Chem. 1982, 257:10364-10371.
301. Toh Y., Kuninaka S., Oshiro T., Ikeda Y., Nakashima H., Baba H., Kohnoe S., Okamura T., Mori M., Sugimachi K. Overexpression of manganese superoxide dismutase mRNA may correlate with aggressiveness in gastric an colorectal adenocarcinomas. Int. J. Oncol. 2000, 17:107-112.
302. Tortora V., Quijano C., Freeman B., Radi R., Castro L. Mitochondrial aconitase reaction with nitric oxide, S-nitrosoglutathione, and peroxynitrite: mechanisms and relative contributions to aconitase inactivation. Free Radic. Biol. Med. 2007, 42:1075-1088.
303. Tracy K., Dibling B.C., Spike B.T., Knabb J.R., Paul S., Macleod K.F. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol. Cell. Biol. 2007, 27:6229-6242.
304. Tretter L., Adam-Vizi V. Generation of reactive oxygen species in the reaction catalyzed by α-ketoglutarate dehydrogenase. J. Neurosci. 2004, 24:7771-7778.
305. 1 complex. J. Biol. Chem. 1990, 265:11409-11412.
306. Tsanou E., Ioachim E., Briasoulis E., Damala K., Charchanti A., Karavasilis V., Pavlidis N., Agnantis N.J. Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinoma. Histol. Histopathol. 2004, 19:807-813.
307. Ufer C., Wang C.C., Borchert A., Heydeck D., Kuhn H. Redox control of mammalian embryo development. Antioxid. Redox Signal. 2010, 13:833-875.
308. Urano M., Kuroda M., Reynolds R., Oberley T.D., St.Clair D.K. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy. Cancer Res. 1995, 55:2490-2493.
309. Valko M., Leibfritz D., Moncol J., Cronin M.T.D., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
310. van Remmen H., Ikeno Y., Hamilton M., Pahlavani M., Wolf N., Thorpe S.R., Alderson N.L., Baynes J.W., Epstein C.J., Huang T.-T., Nelson J., Strong R., Richardson A. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol. Genomics 2003, 16:29-37.
311. Vashchenko N., Abrahamsson P.A. Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities. Eur. Urol. 2005, 47:147-155.
312. Vaughn A.E., Deshmukh M. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat. Cell Biol. 2008, 10:1477-1483.
313. Venkataraman S., Jiang X., Weydert C., Zhang Y., Zhang H.J., Goswami P.C., Ritchie J.M., Oberley L.W., Buettner G.R. Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 2005, 24:77-89.
314. Wallace D.C. Mitochondrial DNA mutations in disease and aging. Environ. Mol. Mutagen. 2010, 51:440-450.
315. Wang G.L., Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 1995, 270:1230-1237.
316. Wang X., Martindale J.L., Liu Y., Holbrook N.J. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signaling pathways on cell survival. Biochem. J. 1998, 333:291-300.
317. Wang M., Kirk J.S., Venkataraman S., Domann F.E., Zhang H.J., Schafer F.Q., Flanagan S.W., Weydert C.J., Spitz D.R., Buettner G.R., Oberley L.W. Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1α and vascular endothelial growth factor. Oncogene 2005, 24:8154-8166.
318. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
319. Warburg O., Posener K., Negelein E. Über den Stoffwechsel der Carcinomzelle. Biochem. Z. 1924, 152:309-344.
320. Ward P.S., Thompson C.B. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 2012, 21:297-308.
321. Waris G., Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J. Carcinog. 2006, 5:14-21.
322. Wefel J.S., Lenzi R., Theriault R., Buzdar A.U., Cruickshank S., Meyers C.A. 'Chemobrain' in breast carcinoma?: a prologue. Cancer 2004, 101:466-475.
323. Weisiger R.A., Fridovich I. Mitochondrial superoxide dismutase. Site of synthesis and intramitochondrial localization. J. Biol. Chem. 1973, 248:4793-4796.
324. Weydert C., Roling B., Liu J., Hinkhouse M.M., Ritchie J.M., Oberley L.W., Cullen J.J. Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase. Mol. Cancer Ther. 2003, 2:361-369.
325. Williams M.D., Van Remmen H., Conrad C.C., Huang T.-T., Epstein C.J., Richardson A. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J. Biol. Chem. 1998, 273:28510-28515.
326. Wispe J.R., Clark J.C., Burhans M.S., Kropp K.E., Korfhagen T.r., Whitsett J.A. Synthesis and processing of the precursor for human mangano-superoxide dismutase. Biochim. Biophys. Acta 1989, 994:30-36.
327. Wong T.S., Rajagopalan S., Townsley F.M., Freund S.M., Petrovich M., Loakes D., Fersht A.R. Physical and functional interactions between human mitochondrial single-stranded DNA-binding protein and tumour suppressor p53. Nucleic Acids Res. 2009, 37:568-581.
328. Wright V.P., Reiser P.J., Clanton T.L. Redox modulation of global phosphatase activity and protein phosphorylation in intact skeletal muscle. J. Physiol. 2009, 587:5767-5781.
329. Xu Y., Porntadavity S., St.Clair D.K. Transcriptional regulation of the human manganese superoxide dismutase gene: the role of specificity protein 1 (Sp1) and activating protein-2 (AP-2). Biochem. J. 2002, 362:401-412.
330. Yakes F.M., van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:514-519.
331. Yamakura F., Kawasaki H. Post-translational modifications of superoxide dismutase. Biochim. Biophys. Acta 2010, 1804:318-325.
332. Yamakura F., Taka H., Fujimura T., Murayama K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J. Biol. Chem. 1998, 273:14085-14089.
333. Yang L.-Y., Chen W.-L., Lin J.-W., Lee S.-F., Lee C.-C., Hung T.I., Wei Y.-H., Shih C.-M. Differential expression of antioxidant enzymes in various hepatocellular carcinoma cell lines. J. Cell. Biochem. 2005, 96:622-631.
334. Yen H.-C., Oberley T.D., Vichitbandha S., Ho Y.-S., St.Clair D.K. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J. Clin. Invest. 1996, 98:1253-1260.
335. Yen H.-C., Oberley T.D., Gairola C.G., Szweda L.I., St.Clair D.K. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. Arch. Biochem. Biophys. 1999, 362:59-66.
336. Yon J.-M., Baek I.-J., Lee B.J., Yun Y.W., Nam S.-Y. Dynamic expression of manganese superoxide dismutase during mouse embryonic organogenesis. Int. J. Dev. Biol. 2011, 55:327-334.
337. Zamocky M., Furtmuller P.G., Obinger C. Evolution of catalases from bacteria to humans. Antioxid. Redox Signal. 2008, 10:1527-1547.
338. Zelko I.N., Mariani T.J., Felz R.J. Superoxide dismutase multigene family: a comparison of CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structure, evolution, and expression. Free Radic. Biol. Med. 2002, 33:337-349.
339. Zhang L., Yu L., Yu C.-A. Generation of superoxide anion by succinate-cytochrome c reductase from bovine heart mitochondria. J. Biol. Chem. 1998, 273:33972-33976.
340. Zhang Y., Smith B.J., Oberley L.W. Enzymatic activity is necessary for the tumor-suppressive effects of MnSOD. Antioxid. Redox Signal. 2006, 8:1283-1293.
341. Zhang H., Bosch-Marce M., Shimoda L.A., Tan Y.S., Baek J.H., Wesley J.B., Gonzalez F.J., Semenza G.L. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 2008, 283:10892-10903.
342. Zhang C., Lin M., Wu R., Wang X., Yang B., Levine A.J., Hu W., Feng Z. Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect. Proc. Natl. Acad. Sci. 2011, 108:16259-16264.
343. Zhao Y., Kiningham K.K., Lin S.-M., St.Clair D.K. Overexpression of MnSOD protects murine fibrosarcoma cells (FSa-II) from apoptosis and promotes a differentiation program upon treatment with 5-azacytidine: involvement of MAPK and NFκB pathways. Antioxid. Redox Signal. 2001, 3:375-386.
344. Zhao Y., Xue Y., Oberley T.D., Kiningham K.K., Lin S.-M., Yen H.-C., Majima H., Hines J., St.Clair D.K. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res. 2001, 61:6082-6088.
345. Zhao Y., Oberley T.D., Chaiswing L., Lin S.-m., Epstein C.J., Huang T.-T., St.Clair D.K. Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model. Oncogene 2002, 21:3836-3846.
346. Zhao Y., Chaiswing L., Oberley T.D., Batinic-Haberle I., St.Clair W., Epstein C.J., St Clair D.K. A mechanism-based antioxidant approach for the reduction of skin carcinogenesis. Cancer Res. 2005, 65:1401-1405.
347. Zhao Y., Chaiswing L., Velez J.M., Batinic-Haberle I., Colburn N.H., Oberley T.D., St.Clair D.K. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res. 2005, 65:3745-3750.
348. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., Simons J.W. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 1999, 59:5830-5835.
349. Zhou Z., Kang Y.J. Cellular and subcellular localization of catalase in the heart of transgenic mice. J. Histochem. Cytochem. 2000, 48:585-594.
350. Zhou S., Kachhap S., Sun W., Wu G., Chuang A., Poeta L., Grumbine L., Mithani S.K., Chatterjee A., Koch W., Westra W.H., Maitra A., Glazer C., Carducci M., Sidransky D., McFate T., Verma A., Califano J.A. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc. Natl. Acad. Sci. 2007, 104:7540-7545.
351. Zhou W., Capello M., Fredolini C., Racanicchi L., Piemonti L., Liotta L.A., Novelli F., Petricoin E.F. Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells. J. Proteome Res. 2012, 11:554-563.